Skip to main content

Postpartum clinical trials at University of California Health

1 in progress, 0 open to eligible people

Showing trials for
  • CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy

    Sorry, not yet accepting patients

    This is a Phase I/II, multicenter, open-label, non-randomized study with four groups to characterize the pharmacokinetics and safety of Cabotegravir (CAB) and Rilpivirine (RPV) long-acting injectable (LA) during pregnancy and postpartum among people with HIV-1 viral suppression and their infants.

    at UCSD

Last updated: